Opening session


Endogenous Contrast Imaging



Yüklə 1,81 Mb.
səhifə15/35
tarix26.10.2017
ölçüsü1,81 Mb.
#15324
1   ...   11   12   13   14   15   16   17   18   ...   35

Endogenous Contrast Imaging

Room A9 16:00-18:00 Moderators: Ravinder Reddy and David J. Tozer

16:00 332. Observation of Frequency Shifts Induced by Chemical Exchange in Brain Tissue

Karin Shmueli1, Steve Dodd2, T-Q Li3, Jeff H. Duyn1

1Advanced MRI Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States; 2Functional and Molecular Metabolism Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States; 3Department of Medical Physics, Karolinska Huddinge, Stockholm, Sweden

Water-macromolecular exchange has been proposed to explain brain gray and white matter frequency (phase) contrast. We extended previous observations of exchange-induced frequency shifts (fexch) in protein solutions by performing chemical shift imaging experiments using reference chemicals (TSP and dioxane) to observe positive fexch in fixed human and fresh pig brain tissue. Substantial negative GM-WM δfexch was observed which was similar for all tissues and references but opposite to in-vivo GM-WM frequency contrast, implying that tissue magnetic susceptibility may have a greater contribution. Exchange should therefore be included in frequency contrast models but is insufficient to explain in-vivo GM-WM phase contrast.



16:12 333. Classical Interpretation of T1rho and T2rho Relaxation

Michael Carl1, Mark Bydder2, Eric Han1, Graeme Bydder2

1GE Healthcare, Waukesha, WI, United States; 2University of California, San Diego, CA, United States

We present a simulation model based solely on classical equations to study spin-lattice relaxation in the rotating frame. Without the confound of a quantum mechanical treatment, this model allows for an intuitive understanding of spin locking such as T1rho dispersion, oscillations caused by residual dipolar interactions (RDI), and T2rho.



16:24 334. Quantitative T1rho Imaging Using Phase Cycling for B0 and B1 Field Inhomogeneity Compensation

Weitian Chen1, Atsushi Takahashi1, Eric T. Han1

1MR Applied Science Lab, GE Healthcare, Menlo Park, CA, United States

T1rho imaging is promising in clinical applications such as early detection of osteoarthritis. T1rho imaging, however, is sensitive to B0 and B1 RF field inhomogeneities. In this work, we report on a phase cycling method to eliminate B1 RF inhomogeneity effects in T1rho imaging. The presences of B0 field inhomogeneity can compromise B1 RF inhomogeneity compensation approaches. We present a method which combines the phase cycling approach with a composite RF pulse scheme proposed by Dixon et al for simultaneous compensation of B0 and B1 RF field inhomogeneity in T1rho imaging. The proposed T1rho RF preparation methods can be combined with an SNR-efficient 3D T1rho imaging method MAPSS without compromising scan time.



16:36 335. Quantitative Magnetization Transfer Imaging of Human Brain at 3T Using Selective Inversion Recovery

Richard D. Dortch1,2, Ke Li1,2, Ashish A. Tamhane3, E B. Welch2,4, Dan F. Gochberg1,2, John C. Gore1,2, Seth A. Smith1,2

1Department of Radiology and Radiological Sciences, Vanderbilt University, Nashville, TN, United States; 2Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, TN, United States; 3Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, United States; 4MR Clinical Science, Philips Healthcare, Cleveland, OH, United States

Quantitative magnetization transfer (qMT) yields quantitative information about interactions between immobile macromolecular protons and free water protons. Because of its relatively short scan times, the pulsed, off-resonance saturation qMT approach is most commonly employed on clinical systems; however, it suffers from complicated data analysis and sensitivity to macromolecular proton lineshape assumptions. The selective inversion recovery (SIR) approach does not suffer from these shortcomings, but has not been widely implemented on clinical systems. In this study, the SIR approach was implemented on a clinical 3T system. The resultant qMT parameters in healthy brain were in good agreement with previously published values.


16:48 336. Magnetization Transfer Mapping of Myelinated Fiber Tracts in Living Mice at 9.4 T

Susann Boretius1, Peter Dechent2, Jens Frahm1, Gunther Helms2

1Biomedizinische NMR Forschungs GmbH, Max-Planck-Institut für biophysikalische Chemie, Göttingen, Germany; 2MR-Research in Neurology and Psychiatry, University Medical Center, Göttingen, Germany

MRI of mouse models is an integral part of translational research on white matter diseases and myelin disorders. Thus, the delineation of myelinated fiber tracts in mice becomes of growing interest. Here we used in healthy adult mice a novel FLASH-based parameter for magnetization transfer that was recently established for human applications. In comparison to maps of MT ratio and T1, this parameter provides an improved gray-white matter contrast that allows for the visualization of small neuronal fiber bundles such as the mammilothalamic tract and fasciculus retroflexus.



17:00 337. Molecular Mechanisms of Magnetization Transfer

Scott David Swanson1

1Department of Radiology, University of Michigan, Ann Arbor, MI, United States

We present a look at the molecular mechanisms of MT in agarose and gelatin samples. MT is found to be driven by whole water exchange in agarose and proton exchange in gelatin.



17:12 338. CEST-Dixon MRI for Sensitive and Accurate Measurement of Amide Proton Transfer in Humans at 3T

Jochen Keupp1, Holger Eggers1

1Philips Research Europe, Hamburg, Germany

CEST-MRI based measurement of endogenous proteins using the amide proton transfer (APT) signal could find important clinical applications in oncology (tumor metabolism) and in neurology (ischemic acidosis). As APT-MRI is very sensitive to B0 inhomogeneity, we propose to apply multi gradient-echo sequences and derive a B0 map by the Dixon technique, as opposed to previously described methods like full CEST-spectra interpolation or separate water resonance mapping. Furthermore, technical limits for pulse lengths on clinical scanners are addressed and a saturation of 1 second is achieved (human head). Feasibility of APT-MRI within 6 minutes (SENSE R=3) is demonstrated in volunteers at 3T.



17:24 339. Detection of Myo-Inositol In-Vivo Using MR Chemical Exchange Saturation Transfer Imaging (MICEST)

Mohammad Haris1, Kejia Cai1, Anup Singh1, Feliks Kogan1, Walter Witschey1, Hari Hariharan1, Ravinder Reddy1

1CMROI, Department of Radiology, University of Pennsylvania, Philadelphia, PA, United States

In the current study, we demonstrated the mapping of Myo-inositol (MI) in human brain at 7T by exploiting chemical exchange saturation transfer (CEST) of labile hydroxyl proton (-OH) on the MI. The Z-spectrum of MI showed an asymmetry around~0.625ppm downfield to the bulk water resonance. The CEST imaging on healthy human brain clearly shows the distribution of MICEST contrast in gray and white matter regions and negligible contrast from cerebrospinal fluid.



17:36 340. Differentiation Between Glioma and Radiation Necrosis Using Molecular Imaging of Endogenous
Proteins and Peptides

Jinyuan Zhou1, Erik Tryggestad2, Zhibo Wen1, Bachchu Lal3, Tingting Zhou1, Rachely Grossman4, Kun Yan1, Silun Wang1, De-Xue Fu5, Eric Ford2, John Laterra3, Peter C.M. van Zijl1

1Department of Radiology, Johns Hopkins University, Baltimore, MD, United States; 2Department of Radiation Oncology, Johns Hopkins University, Baltimore, MD, United States; 3Department of Neurology, Kennedy Krieger Institute, Baltimore, MD, United States; 4Department of Neurosurgery, Johns Hopkins University, Baltimore, MD, United States; 5Department of Oncology, Johns Hopkins University, Baltimore, MD, United States

We show that it is possible to differentiate between glioma and radiation necrosis using the amide proton signals of endogenous cellular proteins and peptides as imaging biomarker. Using a radiation necrosis model (dose, 40 Gy; area, 10x10 mm2) and a SF188/V+ human glioma model in rats, tumors and radiation necrosis had similar conventional MRI features. However, gliomas were consistently hyperintense on amide proton transfer (APT) images, while radiation necrosis (observed about six months post-radiation) was hypointense to isointense. APT MRI as an imaging biomarker for tumor presence provides unique visual information for assessing active tumor versus treatment-related injury, such as radiation necrosis.



17:48 341. Fast T1 Mapping Using Modified Double-Inversion Recovery Pre-Pulse

Marcelo E. Andia1, Rene M. Botnar1

1Division of Imaging Sciences, Kings College London, London, United Kingdom

In this work we present a new technique for fast T1 estimation where the intensity of each pixel is linearly related to its T1 value. The technique is based on a modified Double Inversion Recovery pre-pulse and only requires the acquisition of a single 2D or 3D dataset. The technique was validated in a T1 phantom and in a pre-clinical study of renal perfusion using a gadolinium based contrast agent. Potential applications include fast T1 quantification in myocardial perfusion, infarct or fibrosis imaging.


Cardiac MR Study Group
Room K1 18:15 - 20:15

Agenda:

Discussion of Goals of Cardiac MR Study Group

Albert de Roos, M.D., University Hospital Leiden, Leiden, The Netherlands and

John Oshinski, Ph.D., Emory University, Atlanta, GA, USA

Presentation of Flow Visualization in the Left Ventricle

Tino Ebbers, Ph.D., Linköping University, Linköping, Sweden

20:15 Adjourn


Current Issues in Brain Function
Room K2 18:15 - 20:15

18:15 Business Meeting, and Introduction of New Committee Members
18:30 GABA & fMRI

Richard Edden, Ph.D., Johns Hopkins University, Baltimore, MD, USA


18:50 Optogenetics & fMRI

Mark Lythgoe, Ph.D., University College London, London, UK


19:10 Real Time fMRI

Nikolaus Weiskopf, Ph.D., University College London, London, UK

Stephen LaConte, Ph.D., Baylor College of Medicine, Houston, TX, USA

Stefan Posse, Ph.D., University of New Mexico, Albuquerque, NM, USA

Rainer Goebel, BIC- Maastricht, Maastricht, The Netherlands
20:15 Adjourn


Dynamic NMR Spectroscopy Study Group
Victoria Hall 18:15 - 20:15

18:15 Business Meeting
18:30 Scientific Meeting – “In vivo MRS Challenges & New Solutions for Advancing Biomedical Applications”
18:30 Mitochondrial Dysfunction in Insulin Resistance: What Do We Actually Measure?

Jeanine Prompers, Ph.D., Assistant Professor, Eindhoven University of Technology, Department of Biomedical Engineering, Eindhoven, The Netherlands


19:00 1H Spectroscopy of Lipids in Human Skeletal Muscle at 7T

Craig R. Malloy, M.D., Professor, Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, USA


19:30 Regional Variations of Metabolite Concentrations in the Rat Brain by 1H NMR at 16.4 T

Sung-Tak Hong, M.Sc., Max-Planck Institute for Biological Cybernetics Tuebingen, Baden-Wuerttemberg, Germany


19:42 Can You Really Use the Creatine Kinase Equilibrium to Calculate Free ADP Concentrations?

Christine Habuurs, Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands


19:54 The Role of Cardiac Carbonic Anhydrases In Vivo: A Hyperpolarized 13C NMR Study

Marie Schroeder, Departments of Physiology, Anatomy & Genetics, University of Oxford, Oxford, UK


20:06 Fast 31P Metabolic Imaging of Human Muscle

Isabell Steinseifer, M.Sc., Department of Radiology, Radboud Unversity Nijmegen Medical Centre, Nijmegen, The Netherlands


20:18 Final Discussions
20:30 Adjourn


Hyperpolarized Media MR Study Group
Room A4 18:15 - 20:15

18:15 Study-Group Business
18:30 Statement on the Availability and Price of 3He
18:40 in-vivo Detection of Rat Brain Metabolism Using Hyperpolarized Acetate

Mor Mishkovsky, Ph.D., EPFL, Lausanne, Switzerland


19:00 Structural Response of the Compliant Lung to Different Ventilation Volumes Assessed by Multiple Exchange Time Xenon Transfer Contrast (MXTC)

Isabel Dregely, University of New Hampshire, Durham, NH, USA


19:20 Experimental Investigation of the Limits of Validity of the Physical Basis of a Method for in-vivo Lung Morphometry with 3He Diffusion MRI

Juan M. Parra-Robles, Ph.D., The University of Sheffield, Sheffield, UK


19:35 Acinar Structural Changes in Mild COPD Detected by in-vivo Lung Morphometry with Hyperpolarized 3He MRI

James D. Quirk, Ph.D., Washington University School of Medicine, St. Louis, MO, USA


19:50 Discussion
20:15 Adjourn


Interventional MR Study Group
Room A5 18:15 - 20:15

Overview:

This symposium has two principal aims: (1) to provide guidance for new or inexperienced sites on how to establish an effective IMR program and (2) to address controversies in the field. We will specifically tackle what the ideal field strength is for iMRI sites and openly discuss the necessity of real time MR guidance versus efficient use of previously acquired or iterative intra-procedure MR data. This discussion will focus on cardiac EP ablations.

Agenda:

18:15 Administrative Business


18:30 Running an iMRI program: How We Do It (15-minutes presentations)

Thermal – R. Jason Stafford, Ph.D., University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Neuro – Charles L. Truwit, M.D., University of Minnesota, Minneapolis, MN, USA
19:00 Controversies in iMRI – Optimal Field Strength for IMR

(3 10-minute “position statements”, 15 min panel discussion)

1T Advocate – Ulf Teichgräber, M.D., Charité - Universitätsmedizin Berlin, Berlin, Germany

1.5T Advocate – Clifford R. Weiss, M.D., Johns Hopkins University, Baltimore, MD, USA

3T Advocate – Clare Tempany, M.D., /Kemal Tuncali, Brigham and Women’s Hospital, Boston, MA, USA
19:45 Controversies in iMRI – MR Guided versus MR Assisted for Cardiac EP

(2 10-minute “position statements”, 10 min panel discussion)

MR Guided Advocate – Graham A. Wright, Ph.D., University of Toronto, Toronto, ON, Canada

MR Assisted Advocate – Tobias R. Schaeffter, Ph.D., Kings College London, London, UK


20:15 Adjourn


MR Engineering Study Group
Room A6 18:15 - 20:15

18:15 MRI systems in 2020
Array Systems for All Field Strengths

Mark Griswold, Ph.D., Case Western Reserve University, Cleveland, OH, USA


Next Generation of Magnet Design

Rory Warner, Magnex Scientific Ltd., Oxford, UK


Engineering Problems Remaining to be Solved: A Clinical Perspective

Thomas Grist, M.D., University of Wisconsin, Madison, WI, USA


20:15 Adjourn


MR in Drug Research Study Group
Room A7 18:15 - 20:15

18:15 Business Meeting
18:30 The Great Debates in MR in Drug Research
18:30 MRI for Body Composition Assessment Has Little Value for Drug Development Studies

Moderator: Bradley Wyman, Ph.D.

Pro: Paul Hockings, Ph.D., TBD Con: Jeff Evelhoch, Ph.D., TBD
19:05 MRI is a Superior Modality for Assessing Rheumatoid Arthritis or Osteoarthritis Disease Progression in Drug Related S tudies

Moderator: TBD

Pro: Joshua Farber, M.D., Bradley Wyman, Ph.D. Con: Derek Hill, Ph.D., John Waterton, Ph.D.
19:40 The Use of MRI for Oncology Drug Trials Should be Severely Limited

Moderator: John Hazle, Ph.D.

Pro: Edward Ashton, Ph.D., TBD Con: Yanping Luo, Ph.D., TBD
20:15 Adjourn


Susceptibilty Weighted Imaging Study Group
Room A8 18:15 - 20:15

18:15 Introduction

Juergen Reichenbach, Ph.D., Professor, Universitätsklinikum Jena, Germany
18:30 An Overview of the State of the Art Now in SWI

Juergen Reichenbach, Ph.D., Professor, Universitätsklinikum Jena, Germany


18:45 Iron Associated with MS Lesions, Thalamus & the Basal Ganglia with SWI

Mark Haacke, Ph.D., Director, The MRI Institute for Biomedical Research, Detroit, MI, USA


19:00 Correlating SWI Iron Measurements with MS Disease Progression & CCSVI

Robert Zivadinov, M.D., Ph.D., Director, Buffalo Neuroimaging Analysis Center, Buffalo, NY, USA


19:15 The Role of CCSVI in Multiple Sclerosis

Paolo Zamboni, M.D., Director, Vascular Diseases Center, ITALY


19:30 Phase Image and Iron Content - A Word of Caution

Dmitriy A. Yablonsky, PhD, Professor, Mallinckrodt Institute of Radiology, USA

19:45 Panel Discussion
20:00 Closing Remarks
20:15 Adjourn


MR Safety Study Group
Room A9 18:15 - 20:15



WEDNESDAY

SUNRISE EDUCATIONAL COURSE
CLINICAL INTENSIVE COURSE
Hot Topics in Body MRI: Diffusion II


Room K1 7:00 – 08:00 Organizers: Talissa Altes, Elmar Max Merkle and Bachir Taouli

EDUCATIONAL OBJECTIVES

Upon completion of days 1 and 2 participants should be able to:


  • Explain the physics of DWI methods in body imaging;

  • Apply DWI technique in their practice;

  • Design female pelvic and prostate MR protocols including DWI; and

  • Describe current results of DWI in oncology

Advanced Body Diffusion 1

Moderators: Dow-Mu Koh, M.D., M.R.C.P., and Harriet C. Thoeny, M.D.

07:00 Oncologic Applications of DWI (Including WBDWI)


Ihab Kamel, M.D.
07:30 DWI: Applications in the Pelvis
Nandita M. de Souza, M.D., F.R.C.R.
SUNRISE EDUCATIONAL COURSE
CLINICAL INTENSIVE COURSE
Tissue Contrast in MSK MRI - From Physics to Physiology


Room K2 07:00 – 08:00 Organizer & Moderator: Bernard J. Dardzinski

EDUCATIONAL OBJECTIVES

Upon completion of this course participants should be able to:


  • Describe contrast mechanisms in MSK imaging, most notably in imaging of articular cartilage;

  • Describe the physics of advanced MR sequences;

  • Identify the most suitable new MR sequences for four important indications;

  • Implement current MR protocols for daily practice and be aware of the most useful indications for these techniques.

07:00 Tissue Anisotropy in Tendons and Cartilage
Gary D. Fullerton, Ph.D.
07:30 Structural Organization of Cartilage and the Habituation Hypothesis
Douglas W. Goodwin, M.D.

SUNRISE EDUCATIONAL COURSE

Image Reconstruction

Victoria Hall 07:00 – 08:00 Organizer & Moderator: Elfar Adalsteinsson

EDUCATIONAL OBJECTIVES

Upon completion of this course participants should be able to:


  • Describe the main steps involved in efficient non-Cartesian image reconstruction;

  • Formulate a generalized signal model incorporating gradient encoding, coil sensitivity and Bo inhomogeneity;

  • List the pro’s and con’s of Cartesian and non-Cartesian parallel MRI;

  • Compare compressed sensing, HYPR, and k-t BLAST with respect to their use of prior knowledge;

  • Describe the principles of separating water and fat signals; and

  • Name three different approaches for motion correction and appraise their potential to become routine methods

Parallel Imaging
07:00 Parallel Imaging Reconstruction I: Cartesian
Michael Schacht Hansen, Ph.D.
07:30 Parallel Imaging Reconstruction II: Non-Cartesian
Chunlei Liu, Ph.D.
SUNRISE EDUCATIONAL COURSE

Imaging Biomarkers

Room A1 07:00 – 08:00 Organizers & Moderators: Jeffrey L. Evelhoch and Sabrina M. Ronen

EDUCATIONAL OBJECTIVES

Upon completion of this course participants should be able to:


  • Describe what a biomarker is and how MR can be used as a biomarker;

  • Explain how biomarkers are qualified to be fit for their intended purpose;

  • List requirements for use of MR biomarkers in both preclinical studies and clinical trials; and

  • Give examples of how imaging biomarkers are being used in at least two of the following areas: multiple sclerosis, oncology, cardiovascular diseases and neurodegenerative diseases.

07:00 Preclinical Applications of Imaging Biomarkers
Markus Von Kienlin, Ph.D.
07:30 Quantitiative MR in Multi-Center Trials
Edward Ashton, Ph.D.

SUNRISE EDUCATIONAL COURSE

Brain: An Absolute Beginner’s Guide to Anatomical & Functional MRI

Room A4 07:00 – 08:00 Organizer & Moderator: Geoffrey J.M. Parker

EDUCATIONAL OBJECTIVES

Upon completion of this course participants should be able to:


  • Identify the neuroanatomical and neurophysiological parameters which are accessible to MR measurement;

  • Describe the underlying physics of MR neuroimaging techniques;

  • Describe the data acquisition and analysis techniques most commonly used for anatomical and functional MRI of the brain;

  • Recognize the potential value of advances such as parallel imaging, fast imaging techniques and high magnetic field strengths for imaging the brain; and

  • Name typical clinical applications for which specific MRI techniques are suited.

07:00 Absolute Beginners' Guide to Perfusion MRI
Laura M. Parkes, Ph.D.


Yüklə 1,81 Mb.

Dostları ilə paylaş:
1   ...   11   12   13   14   15   16   17   18   ...   35




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin